Codes / ICD10CM / C50.629

C50.629 Malignant neoplasm of axillary tail of unspecified male breast

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant Neoplasm of Axillary Tail of Unspecified Male Breast
  • Breast Cancer, Axillary Tail (Unspecified, Male)

Summary

Malignant neoplasm of the axillary tail of the unspecified male breast refers to a type of breast cancer that originates in the axillary tail, a small extension of breast tissue extending toward the armpit in males. It involves the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body.

Causes

The exact causes are not fully understood, but breast cancer generally arises from genetic mutations and cellular changes. Factors such as inherited gene mutations (e.g., BRCA1/BRCA2), hormonal influences, and environmental exposures may contribute to its development.

Risk Factors

  • Age (increased risk in older individuals)
  • Family history of breast cancer
  • Genetic predispositions (e.g., BRCA mutations)
  • Previous breast cancer diagnosis
  • Hormonal factors (e.g., estrogen exposure)
  • Lifestyle factors (e.g., obesity, alcohol consumption)

Symptoms

  • A new lump or mass in the breast or axillary area
  • Changes in breast shape or size
  • Dimpling or puckering of breast skin
  • Nipple discharge, inversion, or changes
  • Redness, scaliness, or thickening of breast or nipple skin

Diagnosis

Diagnosis typically involves a combination of clinical examination, imaging studies (e.g., mammography, ultrasound), and tissue biopsy to confirm the presence of malignant cells. Additional tests may be performed to determine the extent of the disease and guide treatment planning.

Treatment Options

Treatment depends on the stage and characteristics of the cancer and may include surgery (e.g., lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, or targeted therapy. A multidisciplinary approach is often used to tailor the treatment plan to the individual patient.

Prognosis and Follow-Up

Prognosis varies based on factors such as the stage at diagnosis, tumor characteristics, and response to treatment. Regular follow-up care, including physical exams, imaging, and blood tests, is essential to monitor for recurrence or progression. Early detection and treatment generally improve outcomes.

Complications

Complications may include local tissue invasion, lymph node involvement, metastasis to distant organs, treatment-related side effects (e.g., fatigue, nausea, or lymphedema), and psychological distress. Advanced disease can lead to significant morbidity and reduced quality of life.

Lifestyle & Prevention

While not all risk factors are modifiable, maintaining a healthy weight, limiting alcohol intake, engaging in regular physical activity, and avoiding tobacco may help reduce overall cancer risk. Genetic counseling and screening may be recommended for individuals with a strong family history or known genetic mutations.

When to Seek Professional Help

Seek medical attention if you notice a new lump, persistent breast changes, or other concerning symptoms. Early evaluation is critical for timely diagnosis and treatment. Follow up with a healthcare provider for routine screenings as recommended based on individual risk factors.

Tips for Medical Coders

Use this code for malignant neoplasms of the axillary tail of the breast in males when the side (right or left) is not specified. Ensure documentation supports the anatomical location and absence of laterality. Verify that the diagnosis aligns with the clinical findings and that no more specific code (e.g., with laterality) is applicable.

Book a walkthrough

C50.629 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.